Federal contract award
75N95022F00001
EXPERIMENTAL VALIDATION OF CANDIDATE ALZHEIMER'S DISEASE TREATMENTS IDENTIFIED BY MULTI-OMICS ANALYSES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 621511 — Medical Laboratories |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | 75N95022D00012 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $638.0K |
| Current contract value | $638.0K |
| Potential contract value / ceiling | $638.0K |
| Start date | Jun 1, 2022 |
| Current end date | May 31, 2023 |
| Potential end date | May 31, 2023 |
| Latest award activity | Jun 3, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 3, 2026 | P00001 | $-0 | EXPERIMENTAL VALIDATION OF CANDIDATE ALZHEIMER'S DISEASE TREATMENTS IDENTIFIED BY MULTI-OMICS ANALYSES |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.